Found: 187
Select item for more details and to access through your institution.
Cellular localization of p-tau217 in brain and its association with p-tau217 plasma levels.
- Published in:
- Acta Neuropathologica Communications, 2022, v. 10, n. 1, p. 1, doi. 10.1186/s40478-021-01307-2
- By:
- Publication type:
- Article
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 5, p. 1, doi. 10.15252/emmm.202217123
- By:
- Publication type:
- Article
The genetic regulation of protein expression in cerebrospinal fluid.
- Published in:
- EMBO Molecular Medicine, 2023, v. 15, n. 1, p. 1, doi. 10.15252/emmm.202216359
- By:
- Publication type:
- Article
Blood‐based biomarkers for Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2022, v. 14, n. 1, p. 1, doi. 10.15252/emmm.202114408
- By:
- Publication type:
- Article
Tau PET correlates with different Alzheimer's disease‐related features compared to CSF and plasma p‐tau biomarkers.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 8, p. 1, doi. 10.15252/emmm.202114398
- By:
- Publication type:
- Article
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 6, p. 1, doi. 10.15252/emmm.202114022
- By:
- Publication type:
- Article
Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2019, v. 11, n. 12, p. N.PAG, doi. 10.15252/emmm.201911170
- By:
- Publication type:
- Article
Amyloid blood biomarker detects Alzheimer's disease.
- Published in:
- EMBO Molecular Medicine, 2018, v. 10, n. 5, p. 1, doi. 10.15252/emmm.201708763
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarker panel for synaptic dysfunction in a broad spectrum of neurodegenerative diseases.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 7, p. 2414, doi. 10.1093/brain/awae032
- By:
- Publication type:
- Article
Diffusion MRI tracks cortical microstructural changes during the early stages of Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 3, p. 961, doi. 10.1093/brain/awad428
- By:
- Publication type:
- Article
Head-to-head comparison of 10 plasma phospho-tau assays in prodromal Alzheimer's disease.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1592, doi. 10.1093/brain/awac333
- By:
- Publication type:
- Article
Phospho-tau with subthreshold tau-PET predicts increased tau accumulation rates in amyloid-positive individuals.
- Published in:
- Brain: A Journal of Neurology, 2023, v. 146, n. 4, p. 1580, doi. 10.1093/brain/awac329
- By:
- Publication type:
- Article
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Untangling the association of amyloid-β and tau with synaptic and axonal loss in Alzheimer's disease.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Longitudinal plasma p-tau217 is increased in early stages of Alzheimer's disease.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Remote and unsupervised digital memory assessments can reliably detect cognitive impairment in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2024, v. 20, n. 7, p. 4775, doi. 10.1002/alz.13919
- By:
- Publication type:
- Article
Blood‐based SNAP‐25 and VAMP‐2 in Alzheimer's disease; relation to cognition, atrophy and synaptic density.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083128
- By:
- Publication type:
- Article
Neuronal pentraxin‐2 by Simoa ‐ a potential synaptic biomarker in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.083007
- By:
- Publication type:
- Article
Identification of Distinct and Shared Biomarkers in Cerebral Small Vessel Disease (SVD) through Proteomic Profiling of Cerebrospinal Fluid.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082927
- By:
- Publication type:
- Article
Relationship between norepinephrine metabolism and plasma markers of tau pathology.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082789
- By:
- Publication type:
- Article
Optimal combination of CSF phosphorylated‐tau forms to predict Alzheimer's disease pathological burden as measured by PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.082746
- By:
- Publication type:
- Article
Lower LC activity during high arousal conditions is related to greater plasma P‐Tau217 concentration in older individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079974
- By:
- Publication type:
- Article
Biofluid phospho‐tau with subthreshold tau‐PET predicts higher rates of tau accumulation: implications for secondary prevention trials.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077204
- By:
- Publication type:
- Article
Effects of biomarker timing on preclinical cognitive trajectories and tau PET accumulation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.077184
- By:
- Publication type:
- Article
Detection of PART in vivo using tau‐PET: preliminary findings using [<sup>18</sup>F]RO948.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079520
- By:
- Publication type:
- Article
CSF Biomarkers and [<sup>18</sup>F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074779
- By:
- Publication type:
- Article
Targeted proteomic profiling in cerebrospinal fluid and plasma identifies biomarkers for Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079731
- By:
- Publication type:
- Article
Microtubule‐binding region tau fragment tau368 as a biomarker of Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079611
- By:
- Publication type:
- Article
Associations of plasma pT205/T205 with Alzheimer's disease pathology and cognitive function: a comparison with pT217/T217 and pT181/T181.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079523
- By:
- Publication type:
- Article
Blood Biomarkers Improve The Diagnostic Accuracy Of Alzheimer's Disease As Compared With Current Diagnostic Standard In the Primary Care Setting.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078819
- By:
- Publication type:
- Article
What do elevated cerebrospinal fluid p‐tau levels signify in the absence of beta‐amyloid pathology?
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078132
- By:
- Publication type:
- Article
Time of the day at sampling affects amyloid‐beta levels in CSF and plasma.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073213
- By:
- Publication type:
- Article
Plasma tau phosphorylation at T217 predicts amyloid deposition in dominantly inherited and late onset Alzheimer disease participants without clinical symptoms.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.079220
- By:
- Publication type:
- Article
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.075367
- By:
- Publication type:
- Article
Proteomics Analysis Identifying New Markers Related to Alzheimer's Disease Pathology In Vivo.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074976
- By:
- Publication type:
- Article
Adjusting for CSF Reference Proteins Improves Biomarker Accuracy.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074764
- By:
- Publication type:
- Article
Investigation of plasma β‐synuclein levels in different stages of Alzheimer´s disease and relation to amyloid and tau‐PET.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.074201
- By:
- Publication type:
- Article
Effects of pre‐analytical sample handling on the performance of plasma phospho‐tau217.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.073683
- By:
- Publication type:
- Article
Effects of biomarker timing on preclinical cognitive trajectories and tau PET accumulation.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.082038
- By:
- Publication type:
- Article
Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081678
- By:
- Publication type:
- Article
CSF Biomarkers and [18F]flutemetamol PET‐Derived Centiloids in Patients with SCD or MCI.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 10, p. 1, doi. 10.1002/alz.081661
- By:
- Publication type:
- Article
Higher plasma β‐synuclein indicates early synaptic degeneration in Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 11, p. 5095, doi. 10.1002/alz.13103
- By:
- Publication type:
- Article
Optimal combinations of CSF biomarkers for predicting cognitive decline and clinical conversion in cognitively unimpaired participants and mild cognitive impairment patients: A multi‐cohort study.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 7, p. 2943, doi. 10.1002/alz.12907
- By:
- Publication type:
- Article
Robustness of CSF Aβ42/40 and Aβ42/P‐tau181 measured using fully automated immunoassays to detect AD‐related outcomes.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 7, p. 2994, doi. 10.1002/alz.12897
- By:
- Publication type:
- Article
Associations between placental growth factor, white matter lesions, and vascular risk factors in non‐demented elderly individuals.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.066527
- By:
- Publication type:
- Article
The Markers in Neuropsychiatric Disorders Study (The MiND Study): moving neurofilament light and other markers into the clinic to improve care for people with symptoms and illnesses of the mind and brain.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.062655
- By:
- Publication type:
- Article
Plasma p‐tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2585, doi. 10.1002/alz.12906
- By:
- Publication type:
- Article
Tau‐PET is superior to phospho‐tau when predicting cognitive decline in symptomatic AD patients.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 6, p. 2497, doi. 10.1002/alz.12875
- By:
- Publication type:
- Article
Confounding factors of Alzheimer's disease plasma biomarkers and their impact on clinical performance.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 4, p. 1403, doi. 10.1002/alz.12787
- By:
- Publication type:
- Article